Anterior Segment Bioavailability

Anterior Segment Bioavailability is a pharmacokinetic metric that quantifies the extent and rate of drug delivery to the anterior segment of the eye following topical administration, distinguishing it from systemic or posterior segment bioavailability by focusing on localized ocular exposure.

2

Publications

67

Citations

10

Authors

6

Institutions

Publications per year

2017–2026

1

Authors

10

  1. IK
    Iiro Kiiski

    University of Helsinki, Finland

    1 publications · 53 citations

    1

    h-index

  2. CN
    Christopher N. Ta

    Stanford University, United States

    1 publications · 14 citations

    1

    h-index

  3. AR
    Anna‐Kaisa Rimpelä

    University of Helsinki, Finland

    1 publications · 53 citations

    1

    h-index

  4. MS
    Mark S. Blumenkranz

    Stanford University, United States

    1 publications · 14 citations

    1

    h-index

  5. FD
    Feng Deng

    University of Helsinki, Finland

    1 publications · 53 citations

    1

    h-index

1–5 of 10

Venues

  1. Pharmaceutics

    1 publications · 53 citations

    1

    h-index

  2. American Journal of Ophthalmology

    1 publications · 14 citations

    1

    h-index

1–2